Documento fuente o registro público
FDA 510(k) K221801 — ADVIA Centaur® Anti-Müllerian Hormone (AMH)
FDA 510(k) index record K221801. Device: ADVIA Centaur® Anti-Müllerian Hormone (AMH). Applicant as listed: Siemens Healthcare Diagnostics, Inc.. Decision date: 2023-06-02.
Fuente
"device_name": "ADVIA Centaur® Anti-Müllerian Hormone (AMH)"
Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K221801.
Device name: ADVIA Centaur® Anti-Müllerian Hormone (AMH). Applicant as listed: Siemens Healthcare Diagnostics, Inc..
Decision date: 2023-06-02. Decision wording: Substantially Equivalent.
Product code: PQO. Regulation: 21 CFR 862.1092. Medical specialty: Clinical Chemistry.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.